Efficacy Testing of Les Mills Pilates

NCT ID: NCT06409858

Last Updated: 2024-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-31

Study Completion Date

2024-08-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: Determine the effect of an 8-week intervention of the new group fitness program Les Mills Pilates on balance, core stability, abdominal, back, and hip muscle endurance, flexibility, and mood. Research questions: Does doing Les Mills Pilates twice per week for 8 weeks result in: 1) increased balance, 2) increased core stability, 3) increased abdominal, back, and hip muscle endurance, 4) increased flexibility, and 5) improved mood? Intended outcomes: this study will determine the efficacy of a new group fitness program developed by Les Mills International. Results will be used to help refine the program, as well as in marketing of the program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Core Muscle Endurance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

All participants will receive twice weekly Pilates classes for 8 weeks

Group Type EXPERIMENTAL

Pilates

Intervention Type OTHER

Twice-weekly mat Pilates class for 8 weeks, either in person or online (depending on participant availability)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pilates

Twice-weekly mat Pilates class for 8 weeks, either in person or online (depending on participant availability)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Not participating in regular core training (no more than 10 minutes per session, twice per week)
* Active (150 minutes per week of moderate to vigorous physical activity)

Exclusion Criteria

* any neurological, cardiovascular, or musculoskeletal conditions that would put them at risk while participating, or be made worse by exercise
* Participants with current lower back pain
* Pregnant participants
Minimum Eligible Age

19 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Les Mills International

UNKNOWN

Sponsor Role collaborator

University of the Fraser Valley

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gillian Hatfield

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gillian L Hatfield, PhD

Role: PRINCIPAL_INVESTIGATOR

University of the Fraser Valley

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gillian L Hatfield, PhD

Role: CONTACT

604-504-7441 ext. 2217

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

101548

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.